Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-22-007494

Options or other derivatives

  • General Counsel acquired 32,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DENYES NANCY General Counsel 2022-02-03 Grant or award · Employee Stock Option (right to buy) +21,500 21,500 D
DENYES NANCY General Counsel 2022-02-03 Grant or award · Restricted Stock Units +10,750 10,750 D
Loading xslF345X03/doc4.xml…